You have 8 free searches left this month | for more free features.

lowering effect

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hyperlipidemias Trial in Belfast (Fenugreek Seed Tea, Black Tea)

Recruiting
  • Hyperlipidemias
  • Fenugreek Seed Tea
  • Black Tea
  • Belfast, Northern Ireland, United Kingdom
  • +1 more
May 5, 2023

Breast Cancer Invasive Trial in Seoul (Leuplin or zoladex)

Recruiting
  • Breast Cancer Invasive
  • Leuplin or zoladex
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 16, 2022

Primary Open Angle Glaucoma, Intraocular Pressure, Glaucoma Surgery Trial (High frequency deep sclerotomy (HFDS))

Not yet recruiting
  • Primary Open Angle Glaucoma
  • +2 more
  • High frequency deep sclerotomy (HFDS)
  • (no location specified)
Aug 15, 2022

Hypertension Trial in Boston (Sleep Extension, Sleep Timing)

Active, not recruiting
  • Hypertension
  • Sleep Extension
  • Sleep Timing
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
May 20, 2022

Telenursing Lipid Lowering Medication Adherence Trial (SMS reminder massages about adherence)

Not yet recruiting
  • Telenursing Lipid Lowering Medication Adherence
  • SMS reminder massages about adherence
  • (no location specified)
May 15, 2023

High Myopia, Glaucoma, Suspect Trial in Guangzhou (Assigned Interventions: IOP-lowering eye drops)

Not yet recruiting
  • High Myopia
  • Glaucoma, Suspect
  • Assigned Interventions: IOP-lowering eye drops
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Apr 29, 2023

Hypercholesterolemia Trial (MK0653, ezetimibe / Duration of Treatment: 4 Weeks)

Completed
  • Hypercholesterolemia
  • MK0653, ezetimibe / Duration of Treatment: 4 Weeks
  • (no location specified)
Feb 7, 2022

Chronic Kidney Diseases, Hyperphosphatemia Trial in Chengdu (AP-306, Sevelamer Carbonate)

Recruiting
  • Chronic Kidney Diseases
  • Hyperphosphatemia
  • Chengdu, Sichuan, China
    Sichuan Provincial People's Hospital
Mar 9, 2023

Hypercholesterolemia Trial in Helsinki (Plant stanol ester, Placebo)

Active, not recruiting
  • Hypercholesterolemia
  • Plant stanol ester
  • Placebo
  • Helsinki, Finland
    Nightingale Health plc
Dec 2, 2021

Above Optimal Plasma LDL Concentrations Trial in Winnipeg, Toronto (muffin)

Active, not recruiting
  • Above Optimal Plasma LDL Concentrations
  • muffin
  • Winnipeg, Manitoba, Canada
  • +1 more
Oct 24, 2022

Adverse Effect of Cardiovascular Medications (Diagnosis) Trial in Zibo (Evolocumab combined with statins, Statin)

Recruiting
  • Adverse Effect of Cardiovascular Medications (Diagnosis)
  • Evolocumab combined with statins
  • Statin
  • Zibo, Shandong, China
    Zibo Central Hospital
Mar 24, 2023

Hypercholesterolemia Trial in Helsinki (Product that contains plant stanol ester, Placebo product)

Completed
  • Hypercholesterolemia
  • Product that contains plant stanol ester
  • Placebo product
  • Helsinki, Finland
    Nightingale Health plc
Dec 2, 2021

Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost SR, LUMIGAN)

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Dothan, Alabama
  • +5 more
May 17, 2022

Statin, Risk Factors, Primary Prevention Trial in Nanjing (Coronary Computed Tomography Angiography, No Intervention)

Not yet recruiting
  • Statin
  • +2 more
  • Coronary Computed Tomography Angiography
  • No Intervention
  • Nanjing, Jiangsu, China
    Research Institute Of Medical Imaging Jinling Hospital
Feb 15, 2023

Dyslipidemias Trial in Samara (Combined Lipid-lowering Therapy)

Recruiting
  • Dyslipidemias
  • Combined Lipid-lowering Therapy
  • Samara, Russian Federation
    Samara Regional Cardiology Dispansery
Nov 17, 2022

Hypercholesterolemia Trial in Jaipur (Cardio-complement)

Completed
  • Hypercholesterolemia
  • Cardio-complement
  • Jaipur, Rajasthan, India
    Gyansanjeevani
Jul 16, 2021

Glaucoma, Suspect, High Myopia Trial in Guangzhou (IOP lowering eye drops)

Recruiting
  • Glaucoma, Suspect
  • High Myopia
  • IOP lowering eye drops
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
May 4, 2022

Hypercholesterolemia Trial (ezetimibe (+) simvastatin, Comparator : rosuvastatin calcium, Comparator: Placebo (unspecified))

Completed
  • Hypercholesterolemia
  • ezetimibe (+) simvastatin
  • +2 more
  • (no location specified)
Feb 7, 2022

ST Elevation Myocardial Infarction (STEMI) Trial (Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA])

Not yet recruiting
  • ST Elevation Myocardial Infarction (STEMI)
  • Rosuvastatin 20 mg
  • Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA]
  • (no location specified)
Feb 1, 2023

Diabetic Peripheral Neuropathy Trial in Wenzhou (hypoglycemic Agents(metformin), lipid-lowering drug(Statin))

Recruiting
  • Diabetic Peripheral Neuropathy
  • hypoglycemic Agents(metformin)
  • lipid-lowering drug(Statin)
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
Sep 11, 2023

Hypercholesterolemia Trial in Edmonton (Kefir)

Completed
  • Hypercholesterolemia
  • Kefir
  • Edmonton, Alberta, Canada
    University of Alberta
Jan 11, 2023

Obesity, Drug Effect Trial in Oslo (Mesna)

Completed
  • Obesity
  • Drug Effect
  • Oslo, Norway
    University of Oslo
May 18, 2022

Acute Coronary Syndrome, Myocardial Infarction, Ischemic Stroke Trial in Dudley (Decision Support System (DSS))

Recruiting
  • Acute Coronary Syndrome
  • +2 more
  • Decision Support System (DSS)
  • Dudley, West Midlands, United Kingdom
    Russell's Hall Hospital
Apr 25, 2023

"My A:Care" and "Smart Coach" on Lipid-lowering Treatment

Recruiting
  • Dyslipidemia
  • My A:care
  • Smart Coach
  • Khon Kaen, Thailand
    Chatlert Mueang Pongchaiyakul
May 9, 2022

Blood Pressure Trial in Coleraine (Riboflavin, Folic acid, Placebo)

Completed
  • Blood Pressure
  • Riboflavin
  • +2 more
  • Coleraine, Co.Londonderry, United Kingdom
    Human Intervention Studies Unit, Ulster University
Jun 11, 2021